Follow RSS for latest reports on this topicXARELTO (Rivaroxaban) - Market Research and Reports

  • XARELTO® is the first and only oral, selective Factor Xa inhibitor with a demonstrated safety profile in multiple indications approved by the FDA.
  • XARELTO® is a prescription medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. For patients currently well managed on warfarin, there is limited information on how XARELTO® and warfarin compare in reducing the risk of stroke.
  • XARELTO® is also a prescription medicine used to treat deep vein thrombosis and pulmonary embolism, and to help reduce the risk of these conditions occurring again.
  • XARELTO® is also a prescription medicine used to reduce the risk of forming a blood clot in the legs and lungs of people who have just had knee or hip replacement surgery.

Source: http://www.xarelto-us.com/

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found 13 reports that matched your search.

Refine your search, and find more matches, using the form above.

Venous Thromboembolism Treatment Market: By Type (Deep Venous Thrombosis, and Pulmonary Embolism); By Treatment (Heparin, Apixaban, Dabigatran, Rivaroxaban, Edaxaban, Others) & By Region (Europe, North America, Asia-Pacific, RoW)-Forecast (2016-2022) [Report Updated: 27-09-2016]

Venous Thromboembolism (VTE) is a lethal disorder that affects the hospitalized and non-hospitalized patients, recurs frequently, and results in long-term complications including chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS). It includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). Globally, development of efficient and advanced technol...Read More >>>

Published:
2016-09-27

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2016-02-03

Published by: Industry ARC

Prices Starting From:
$5250

Additional Searches

You may also like to search separately for: XARELTO (Rivaroxaban)

We Stock...

{STICKYFOOTERMOBILE}